Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Gynecologic Oncology Group

ClinicalTrials.gov Identifier:

NCT00899093

First received: May 9, 2009

Last updated: December 23, 2014

Last verified: December 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2100 (Final data collection date for primary outcome measure)